Drug Profile
Minactivin
Alternative Names: PAI-2; Plasminogen activator inhibitor (PAI) type 2Latest Information Update: 19 Mar 2003
Price :
$50
*
At a glance
- Originator Human Therapeutics; Network Limited
- Developer Network Limited
- Class Antineoplastics; Blood coagulation factors
- Mechanism of Action Plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Psoriasis; Skin ulcer
Most Recent Events
- 19 Mar 2003 No development reported - Phase-II for Psoriasis in Australia (Topical)
- 19 Mar 2003 No development reported - Phase-II for Skin ulcer in Australia (Topical)
- 30 Jun 2002 Biotech Australia has been acquired by, and merged into, GroPep